These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1194 related items for PubMed ID: 20422687

  • 1. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF.
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [Abstract] [Full Text] [Related]

  • 2. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):472-9. PubMed ID: 25680593
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
    Yi JH, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS.
    Hematol Oncol; 2010 Jun 01; 28(2):57-61. PubMed ID: 19593742
    [Abstract] [Full Text] [Related]

  • 4. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
    Khong PL, Huang B, Lee EY, Chan WK, Kwong YL.
    J Nucl Med; 2014 Jun 01; 55(6):911-6. PubMed ID: 24819420
    [Abstract] [Full Text] [Related]

  • 5. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF.
    Kaohsiung J Med Sci; 2015 Mar 01; 31(3):130-7. PubMed ID: 25744235
    [Abstract] [Full Text] [Related]

  • 6. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S, Li G, Bural G, Alavi A.
    Acta Radiol; 2009 Mar 01; 50(2):201-4. PubMed ID: 19089692
    [Abstract] [Full Text] [Related]

  • 7. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K, Luo XM, Zhou SH, Liu JH, Yan SX, Lu ZJ, Yang SY, Lin LL, Dong MJ.
    Cancer Biother Radiopharm; 2012 Dec 01; 27(10):685-93. PubMed ID: 22834634
    [Abstract] [Full Text] [Related]

  • 8. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.
    Ann Nucl Med; 2009 Jun 01; 23(4):349-54. PubMed ID: 19340526
    [Abstract] [Full Text] [Related]

  • 9. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.
    J Nucl Med; 2013 Aug 01; 54(8):1244-50. PubMed ID: 23674577
    [Abstract] [Full Text] [Related]

  • 10. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
    Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA.
    Clin Lymphoma Myeloma; 2008 Apr 01; 8(2):94-9. PubMed ID: 18501102
    [Abstract] [Full Text] [Related]

  • 11. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
    Akkas BE, Vural GU.
    Rev Esp Med Nucl Imagen Mol; 2014 Apr 01; 33(3):148-52. PubMed ID: 24094371
    [Abstract] [Full Text] [Related]

  • 12. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
    Wu HB, Wang QS, Wang MF, Li HS, Zhou WL, Ye XH, Wang QY.
    Nucl Med Commun; 2010 Mar 01; 31(3):195-200. PubMed ID: 20009963
    [Abstract] [Full Text] [Related]

  • 13. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):548-53. PubMed ID: 21277108
    [Abstract] [Full Text] [Related]

  • 14. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.
    Radiology; 2007 Jul 01; 244(1):257-62. PubMed ID: 17581905
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study.
    Byun BH, Na II, Cheon GJ, Kang HJ, Kim KM, Lee SS, Ryoo BY, Choi CW, Lim SM, Yang SH.
    Ann Nucl Med; 2008 Oct 01; 22(8):645-51. PubMed ID: 18982466
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
    Genestreti G, Moretti A, Piciucchi S, Tiseo M, Bersanelli M, Scarlattei M, Scarpi E, Dubini A, Matteucci F, Sanna S.
    Technol Cancer Res Treat; 2012 Apr 01; 11(2):163-7. PubMed ID: 22335410
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H.
    J Nucl Med; 2010 Dec 01; 51(12):1833-40. PubMed ID: 21078787
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
    Cremerius U, Fabry U, Neuerburg J, Zimny M, Bares R, Osieka R, Büll U.
    Nuklearmedizin; 2001 Feb 01; 40(1):23-30. PubMed ID: 11373935
    [Abstract] [Full Text] [Related]

  • 19. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
    Papajík T, Mysliveček M, Sedová Z, Buriánková E, Procházka V, Koranda P, Raida L, Kubová Z, Palová M, Kučerová L, Flodr P, Jarkovský J, Dušek L, Indrák K.
    Eur J Haematol; 2011 Jan 01; 86(1):32-7. PubMed ID: 20874822
    [Abstract] [Full Text] [Related]

  • 20. No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study.
    Wu X, Korkola P, Pertovaara H, Eskola H, Järvenpää R, Kellokumpu-Lehtinen PL.
    Eur J Radiol; 2011 Aug 01; 79(2):e117-21. PubMed ID: 21596501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.